EU Panel Blocks Merck KGaA (MKGAF.PK)'s (JOBS) Erbitux in Lung Cancer
11/20/2009 7:03:41 AM
More...
|
Breast Cancer Vaccine Tests German Merck KGaA (MKGAF.PK)'s $1 Billion Strategy
11/4/2009 7:17:14 AM
More...
|
Merck KGaA (MKGAF.PK) (JOBS) Acquires Bioscience Company, Bangalore Genei Private Ltd. in India
10/13/2009 7:11:56 AM
More...
|
Merck KGaA (MKGAF.PK) Seeks FDA Approval for First MS Pill
9/30/2009 11:27:19 AM
More...
|
Merck KGaA (MKGAF.PK)'s (JOBS) Erbitux Extends Life in One Study, Fails in Second
9/23/2009 6:52:58 AM
More...
|
New Data Shows Promise of German Merck KGaA (MKGAF.PK)'s MS Drug
9/11/2009 8:34:44 AM
More...
|
Critical Outcome Technologies Inc. Announces Pilot Project Conclusion; Merck KGaA (MKGAF.PK) Decides to Discontinue Partnership
8/18/2009 11:01:09 AM
More...
|
R&D Costs Push Merck KGaA (MKGAF.PK)'s Profit Down 48 Percent
7/27/2009 7:00:42 AM
More...
|
Merck KGaA (MKGAF.PK) Falls; EU Rejects Erbitux for Lung Cancer
7/27/2009 6:51:10 AM
More...
|
BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA (MKGAF.PK)
7/15/2009 8:48:45 AM
More...
|
|